109 related articles for article (PubMed ID: 35227226)
21. Using clinical cancer registry data for estimation of quality indicators: Results from the Norwegian breast cancer registry.
Hartmann-Johnsen OJ; Kåresen R; Schlichting E; Naume B; Nygård JF
Int J Med Inform; 2019 May; 125():102-109. PubMed ID: 30914174
[TBL] [Abstract][Full Text] [Related]
22. Surveillance of waiting times for access to treatment: a registry-based computed approach in breast cancer care.
Quillet A; Defossez G; Ingrand P
Eur J Cancer Care (Engl); 2016 Sep; 25(5):764-73. PubMed ID: 26223961
[TBL] [Abstract][Full Text] [Related]
23. Regional variations in cancer survival: Impact of tumour stage, socioeconomic status, comorbidity and type of treatment in Norway.
Skyrud KD; Bray F; Eriksen MT; Nilssen Y; Møller B
Int J Cancer; 2016 May; 138(9):2190-200. PubMed ID: 26679150
[TBL] [Abstract][Full Text] [Related]
24. Association of β-Blocker Use at Time of Radical Prostatectomy With Rate of Treatment for Prostate Cancer Recurrence.
Sivanesan S; Taskén KA; Grytli HH
JAMA Netw Open; 2022 Jan; 5(1):e2145230. PubMed ID: 35080602
[TBL] [Abstract][Full Text] [Related]
25. Waiting times for radiotherapy: variation over time and between cancer networks in southeast England.
Robinson D; Massey T; Davies E; Jack RH; Sehgal A; Møller H
Br J Cancer; 2005 Apr; 92(7):1201-8. PubMed ID: 15785752
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic routes and time intervals for patients with colorectal cancer in 10 international jurisdictions; findings from a cross-sectional study from the International Cancer Benchmarking Partnership (ICBP).
Weller D; Menon U; Zalounina Falborg A; Jensen H; Barisic A; Knudsen AK; Bergin RJ; Brewster DH; Cairnduff V; Gavin AT; Grunfeld E; Harland E; Lambe M; Law RJ; Lin Y; Malmberg M; Turner D; Neal RD; White V; Harrison S; Reguilon I; ; Vedsted P
BMJ Open; 2018 Nov; 8(11):e023870. PubMed ID: 30482749
[TBL] [Abstract][Full Text] [Related]
27. Medical complexity and time to lung cancer treatment - a three-year retrospective chart review.
Stokstad T; Sørhaug S; Amundsen T; Grønberg BH
BMC Health Serv Res; 2017 Jan; 17(1):45. PubMed ID: 28095840
[TBL] [Abstract][Full Text] [Related]
28. Comparison of elapsed times from breast cancer detection to first adjuvant therapy in Nova Scotia in 1999/2000 and 2003/04.
Rayson D; Saint-Jacques N; Younis T; Meadows J; Dewar R
CMAJ; 2007 Jan; 176(3):327-32. PubMed ID: 17261829
[TBL] [Abstract][Full Text] [Related]
29. Retrospective analysis on timeframes of referral, diagnosis and treatment of patients with endometrial carcinomas in Dunedin Hospital, 2008-2011.
Kang MY; Sykes P; Herbison PY; Petrich S
N Z Med J; 2013 Oct; 126(1384):84-95. PubMed ID: 24162633
[TBL] [Abstract][Full Text] [Related]
30. The Waiting Time of Prostate Cancer Patients in Poland.
Osowiecka K; Nawrocki S; Kurowicki M; Rucinska M
Int J Environ Res Public Health; 2019 Jan; 16(3):. PubMed ID: 30691113
[No Abstract] [Full Text] [Related]
31. [Waiting time for surgery of lung cancer].
Strand TE; Rostad H; Sørum R; Solberg S; Norstein J
Tidsskr Nor Laegeforen; 2006 Aug; 126(15):1894-7. PubMed ID: 16915309
[TBL] [Abstract][Full Text] [Related]
32. The effect of standardised cancer pathways on Danish cancer patients' dissatisfaction with waiting time.
Dahl TL; Vedsted P; Jensen H
Dan Med J; 2017 Jan; 64(1):. PubMed ID: 28007051
[TBL] [Abstract][Full Text] [Related]
33. DaPeCa-2: Implementation of fast-track clinical pathways for penile cancer shortens waiting time and accelerates the diagnostic process--A comparative before-and-after study in a tertiary referral centre in Denmark.
Jakobsen JK; Jensen JB
Scand J Urol; 2016; 50(1):80-7. PubMed ID: 26313502
[TBL] [Abstract][Full Text] [Related]
34. Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1).
Schymura MJ; Kahn AR; German RR; Hsieh MC; Cress RD; Finch JL; Fulton JP; Shen T; Stuckart E
BMC Cancer; 2010 Apr; 10():152. PubMed ID: 20403178
[TBL] [Abstract][Full Text] [Related]
35. Predictors of preoperative delays before radical cystectomy for bladder cancer in Quebec, Canada: a population-based study.
Santos F; Dragomir A; Kassouf W; Franco EL; Aprikian A
BJU Int; 2015 Mar; 115(3):389-96. PubMed ID: 24656061
[TBL] [Abstract][Full Text] [Related]
36. Delays to diagnosis and treatment of lung cancer in Australia: healthcare professional perceptions of actual versus acceptable timeframes.
Malalasekera A; Dhillon HM; Blinman PL; Kao SC; Vardy JL
Intern Med J; 2018 Sep; 48(9):1063-1071. PubMed ID: 29756277
[TBL] [Abstract][Full Text] [Related]
37. Cancer Patient Pathways shortens waiting times and accelerates the diagnostic process of suspected sarcoma patients in Denmark.
Dyrop HB; Safwat A; Vedsted P; Maretty-Nielsen K; Hansen BH; Jørgensen PH; Baad-Hansen T; Bünger C; Keller J
Health Policy; 2013 Nov; 113(1-2):110-7. PubMed ID: 24138955
[TBL] [Abstract][Full Text] [Related]
38. Time to diagnosis and treatment for cancer patients in the Netherlands: Room for improvement?
Helsper CCW; van Erp NNF; Peeters PPHM; de Wit NNJ
Eur J Cancer; 2017 Dec; 87():113-121. PubMed ID: 29145037
[TBL] [Abstract][Full Text] [Related]
39. Reducing Bottlenecks to Improve the Efficiency of the Lung Cancer Care Delivery Process: A Process Engineering Modeling Approach to Patient-Centered Care.
Ju F; Lee HK; Yu X; Faris NR; Rugless F; Jiang S; Li J; Osarogiagbon RU
J Med Syst; 2017 Dec; 42(1):16. PubMed ID: 29196866
[TBL] [Abstract][Full Text] [Related]
40. Sick of waiting: Does waiting for elective treatment cause sickness absence?
Dyrstad K; Halvorsen T; Hem KG; Rohde T
Health Policy; 2016 Dec; 120(12):1383-1388. PubMed ID: 27825619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
